Successful hepatic arterial chemoembolization for metastatic melanoma resistant to immune checkpoint inhibitors in an extremely aged patient

The Journal of DermatologyEarly View LETTER TO THE EDITOR Successful hepatic arterial chemoembolization for metastatic melanoma resistant to immune checkpoint inhibitors in an extremely aged patient Yu Kurokami, Yu Kurokami orcid.org/0000-0002-0087-8628 Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorChigusa Yamashita, Chigusa Yamashita Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorKazunori Yokoi, Kazunori Yokoi Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorKyoko Tonomura, Kyoko Tonomura orcid.org/0000-0002-6749-4266 Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorEiji Kiyohara, Eiji Kiyohara orcid.org/0000-0002-0436-4296 Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorYosuke Ishitsuka, Yosuke Ishitsuka Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorYusuke Ono, Yusuke Ono Department of Diagnostic and Interventional radiology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorHiroki Higashihara, Hiroki Higashihara Department of High Precision Image-guided Percutaneous Intervention, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorManabu Fujimoto, Manabu Fujimoto Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorAtsushi Tanemura, Corresponding Author Atsushi Tanemura [email protected] orcid.org/0000-0002-5239-8474 Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan Correspondence Atsushi Tanemura, Department of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. Email: [email protected]Search for more papers by this author Yu Kurokami, Yu Kurokami orcid.org/0000-0002-0087-8628 Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorChigusa Yamashita, Chigusa Yamashita Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorKazunori Yokoi, Kazunori Yokoi Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorKyoko Tonomura, Kyoko Tonomura orcid.org/0000-0002-6749-4266 Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorEiji Kiyohara, Eiji Kiyohara orcid.org/0000-0002-0436-4296 Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorYosuke Ishitsuka, Yosuke Ishitsuka Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorYusuke Ono, Yusuke Ono Department of Diagnostic and Interventional radiology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorHiroki Higashihara, Hiroki Higashihara Department of High Precision Image-guided Percutaneous Intervention, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorManabu Fujimoto, Manabu Fujimoto Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanSearch for more papers by this authorAtsushi Tanemura, Corresponding Author Atsushi Tanemura [email protected] orcid.org/0000-0002-5239-8474 Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan Correspondence Atsushi Tanemura, Department of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. Email: [email protected]Search for more papers by this author First published: 12 July 2023 https://doi.org/10.1111/1346-8138.16894Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Sharma KV, Gould JE, Harbour JW, Linette GP, Pilgram TK, Dayani PN, et al. Hepatic arterial chemoembolization for management of metastatic melanoma. AJR Am J Roentgenol. 2008; 190: 99–104. 2Ahrar J, Gupta S, Ensor J, Ahrar K, Madoff DC, Wallace MJ, et al. Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Cancer Invest. 2011; 29: 49–55. 3Grabosch S, Bulatovic M, Zeng F, Ma T, Zhang L, Ross M, et al. Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles. Oncogene. 2019; 38: 2380–2393. 4Fournel L, Wu Z, Stadler N, Damotte D, Lococo F, Boulle G, et al. Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer. Cancer Lett. 2019; 464: 5–14. 5Bilen MA, Shabto JM, Martini DJ, Liu Y, Lewis C, Collins H, et al. Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy. BMC Cancer. 2019; 19:20190829. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation